Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial update of P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy, being studied in advanced or metastatic solid tumors. The study is …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors [Phase 1]
Phase 1 clinical trial evaluating autologous B7-H3 CAR T cells for recurrent platinum-resistant ovarian cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations
This clinical trial update describes a study evaluating responses to genetic risk modifier testing in women with BRCA1/2 mutations; the stud…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating PLX038 for metastatic platinum-resistant ovarian cancer, fallopian tube cancer, and primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer [Phase 1]
This update indicates the Phase 1b trial combining LDE225 (sonidegib) with paclitaxel in recurrent ovarian cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2026-02-09Clinical Trial Update: A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of IDE161, a PARG inhibitor, is recruiting in patients with several solid tumor types including breast, ovarian, and various l…
-
EMA approval · 2026-02-06EMA Authorised: Alymsys (bevacizumab) — Mabxience Research SL
The EMA authorised Alymsys, a bevacizumab biosimilar from Mabxience Research SL. It is approved for multiple cancer indications including co…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Biobehavioral-Cytokine Interactions in Ovarian Cancer
This completed clinical trial investigated the interactions between biobehavioral factors and cytokine signaling in ovarian cancer.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery [Phase 2]
Bevacizumab is being studied in a Phase 2 trial for ovarian cancer patients undergoing second-look surgery. The trial is currently active bu…
-
EMA approval · 2026-02-05EMA Authorised: Avzivi (bevacizumab) — FGK Representative Service GmbH
EMA authorised Avzivi (bevacizumab) for multiple indications including colorectal cancer, non-small cell lung cancer, renal cell carcinoma, …
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Acupressure for Fatigue in Ovarian Cancer Survivors [NA]
The University of Michigan Rogel Cancer Center completed a clinical trial evaluating acupressure to relieve fatigue in ovarian cancer surviv…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: NeoAdjuvant ChemoTherapy With KELIM Guided Interval vs. Delayed Interval Debulking Surgery [NA]
A clinical trial evaluating neoadjuvant chemotherapy guided by KELIM compared with delayed interval debulking surgery in ovarian cancer; the…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Healthy Volunteers Study
A healthy volunteers clinical study sponsored by the Abramson Cancer Center at Penn Medicine is recruiting, with ovarian cancer and genetic …
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer [EARLY_Phase 1]
An early-phase 1 clinical trial assessed whether statin therapy could slow progression in women with platinum-sensitive ovarian cancer. The …
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer
Real-world data assess the effectiveness and safety of niraparib in Korean women with primary and recurrent epithelial ovarian cancer. The s…
-
CLINICAL_TRIALS withdrawal · 2026-02-04Clinical Trial Update: Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer [NA]
Withdrawn clinical trial evaluating a virtual mental health intervention for fear of progression in women with high-risk or stage III-IV gyn…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours [Phase 1]
Phase 1 study evaluating AVA6000 in solid tumors, assessing safety, pharmacokinetics, and early efficacy; recruitment is ongoing across seve…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing [NA]
This clinical trial update describes evaluating a digital application designed to scale oncologist-initiated genetic testing across multiple…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
This update describes the Moonshot Study's genetic analysis of blood and tissue samples from patients with advanced cancer; the study status…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients
A clinical trial sponsored by Far Eastern Memorial Hospital examines the role of blood perfusion in cervical cancer, cervical intraepithelia…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Fluzoparib Plus Famitinib Maintenance After First-Line Platinum Response in Advanced Ovarian Cancer [Phase 2]
This entry describes a Phase 2 clinical trial evaluating maintenance therapy with a combination of fluzoparib and famitinib after a first-li…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE) [NA]
A prospective biobanking study by Institut Curie (SCANDARE) aims to understand how tumor molecular alterations relate to the tumor microenvi…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Combination of SON-1010 (IL12-FHAB) and Atezolizumab in Patients With Platinum-resistant Ovarian Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating SON-1010 in combination with atezolizumab for platinum-resistant ovarian cancer has been terminated.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2
A prospective cohort trial is recruiting germline BRCA1/BRCA2 variant carriers to study cancer risk in ovarian, fallopian tube, and primary …
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions [NA]
A Mayo Clinic-sponsored clinical trial is evaluating ultrasound microvessel imaging to help characterize ovarian and adnexal lesions, and is…